Drug Search Results
More Filters [+]

Retinol

Alternative Names: retinol, vitamin a, aquasol a, tricyclics, retinolpalmitat, afaxin, del-vi-a, alphalin, vi-dom-a, m.v.c. 9+3, m.v.i.-12 adult, mvc plus, infuvite pediatric (pharmacy bulk package), vitaped, m.v.i. adult (pharmacy bulk package), m.v.i. adult, berocca pn, m.v.i.-12 lyophilized, infuvite adult, m.v.i. pediatric, infuvite pediatric, pediatric infuvite multiple vitamins for infusion, adult infuvite multiple vitamins, pediatric infuvite multiple vitamins, infuvite adult multiple vitamins
Latest Update: 2024-09-26
Latest Update Note: News Article

Product Description

Retinol stimulates fibroblasts to synthesize collagen fibres (stimulates the activity of fibroblasts and increases their number), improves skin elasticity (removes degenerated elastin fibers) and promotes angiogenesis (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791161/)

Mechanisms of Action: LXR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Lebanon | Lithuania | Malaysia | Malta | Mexico | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Slovakia | Slovenia | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Vitamin D Deficiency | Vitamin D Deficiency | Vitamin D Deficiency

Known Adverse Events: Diplopia | Dizziness | Headache | Erythema | Pruritus | Anaphylaxis | Angioedema | Urticaria | Edema

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Retinol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events